Michael Burry joins Buffett's Berkshire in scooping up UnitedHealth shares

Michael Burry's Scion Asset Management, known for his subprime crisis prediction, disclosed significant Q2 positions in UnitedHealth (UNH), including call options with a notional value exceeding $109 million, alongside a smaller common stock stake. This investment in the healthcare insurer, whose shares are down 46% year-to-date amid industry challenges, notably coincided with a substantial purchase by Warren Buffett's Berkshire Hathaway, which acquired over 5 million UNH shares. The convergence of these prominent investors on a deeply discounted stock suggests a potential contrarian value play, though the backward-looking nature of the filings means current positions are unknown.

Analysis

The convergence of two high-profile, yet stylistically different, investors in UnitedHealth (UNH) during the second quarter presents a significant contrarian signal. Michael Burry's Scion Asset Management established a highly bullish stance through call options with a notional value exceeding $109 million, supplemented by a smaller common stock position. Concurrently, Warren Buffett's Berkshire Hathaway made a more substantial, long-term commitment by acquiring over 5 million shares, making UNH its 18th largest holding. This shared interest is particularly noteworthy given the stock's severe underperformance, having declined 46% year-to-date amidst systemic industry challenges and the recent departure of its CEO. While Burry's investment suggests a tactical bet on a price rebound, Buffett's large equity purchase signals a conviction in the firm's underlying long-term value. However, it is critical to note the limitations of this data; the filings are backward-looking, and an active trader like Burry may have already unwound his position, especially as the strike price and expiry of the options remain unknown.

Key Decisions for Investors

• The concurrent investments in UnitedHealth by both Michael Burry and Warren Buffett represent a powerful contrarian signal, warranting a re-evaluation of the stock for a potential value or turnaround opportunity.
• Investors must weigh the bullish signal from these prominent investors against UnitedHealth's significant fundamental headwinds, including a 46% stock decline and a recent CEO exit, which underscore a high-risk profile.
• Given the backward-looking nature of the filings, it is crucial to recognize that Burry's speculative call option position may no longer be active, making Buffett's substantial equity purchase the more durable indicator of long-term conviction.
• Monitor for catalysts that could validate this investment thesis, such as strategic shifts under new leadership or favorable changes in the U.S. healthcare policy environment.